The Fascinating World of Using Molecular Imaging in Primary and Metastatic Breast Cancer
Based on new guidelines for the use of FDG PET/CT in both primary and metastatic breast cancer, Malene Hildebrandt, Clinical Professor and Head of Research at the Department of Nuclear Medicine at Odense University Hospital, presents some clinical issues that need to be addressed.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
